Biodexa Pharmaceuticals (BDRX) EBT Margin (2015 - 2021)
Biodexa Pharmaceuticals (BDRX) posted EBT Margin of 293375.0% for Q4 2020, down 31.42% sequentially from 223237.5% in Q3 2020, and down 28862587.0% YoY from N/an in Q1 2020.
Biodexa Pharmaceuticals (BDRX) EBT Margin (2015 - 2021) Analysis & Trends
Biodexa Pharmaceuticals has reported EBT Margin for 4 years, with the latest figure at 293375.0% in Q4 2020.
- Quarterly EBT Margin fell 28862587.0% year-over-year to 293375.0% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 6522.66% (changed N/A YoY) and the FY2023 annual result came in at 1964.57%, down 75026.0% from the prior year.
- EBT Margin fell to 293375.0% in Q4 2020 per BDRX's latest filing, from 223237.5% in the prior quarter.
- Over five years, EBT Margin peaked at 1449.29% in Q4 2016 and troughed at 293375.0% in Q4 2020.
- A 3-year average of 130702.73% and a median of 113993.32% in 2020 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2016 and 2020: EBT Margin plunged 98941 bps in 2016, then slumped 28862587 bps in 2020.
- Over 3 years, EBT Margin stood at 1449.29% in 2016, then tumbled by 228 bps to 4749.13% in 2019, then plunged by 6077 bps to 293375.0% in 2020.
- According to Business Quant data, EBT Margin over the past three periods registered 293375.0%, 223237.5%, and 4749.13% for Q4 2020, Q3 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1,522.69% |
| Dec 31, 2020 | -293,375.00% |
| Sep 10, 2020 | -223,237.50% |
| Dec 31, 2019 | -4,749.13% |
| Dec 31, 2016 | -1,449.29% |
| Dec 31, 2015 | -459.88% |